The store will not work correctly when cookies are disabled.
3-bromo-N'-((5-(pyridin-2-ylthio)furan-2-yl)methylene)benzohydrazide
ID: ALA4463681
PubChem CID: 56687639
Max Phase: Preclinical
Molecular Formula: C17H12BrN3O2S
Molecular Weight: 402.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(N/N=C/c1ccc(Sc2ccccn2)o1)c1cccc(Br)c1
Standard InChI: InChI=1S/C17H12BrN3O2S/c18-13-5-3-4-12(10-13)17(22)21-20-11-14-7-8-16(23-14)24-15-6-1-2-9-19-15/h1-11H,(H,21,22)/b20-11+
Standard InChI Key: IREZQEIPLSGOCU-RGVLZGJSSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
35.2919 -8.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1091 -8.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3635 -7.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7005 -7.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0418 -7.8038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8107 -9.2410 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.1421 -9.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6591 -10.6484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9899 -11.3948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8033 -11.4818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2849 -10.8163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9515 -10.0726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6992 -6.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9909 -6.0970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9897 -5.2798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2813 -4.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2801 -4.0551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5743 -5.2820 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9873 -3.6478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9864 -2.8314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2775 -2.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5681 -2.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5725 -3.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6937 -2.4220 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
1 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
20 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 402.27 | Molecular Weight (Monoisotopic): 400.9834 | AlogP: 4.35 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.29 | CX Basic pKa: 2.24 | CX LogP: 4.45 | CX LogD: 4.45 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -2.06 |
References
1. (2012) Inhibitors of eya2, |